SEC Suspends Trading Of Company That Sold 'At-Home' COVID-19 Tests
Wellness Matrix Group said the test had been approved but the Food and Drug Administration said it has not authorized any such product.
by Tom Dreisbach
Apr 08, 2020
1 minute
The U.S. Securities and Exchange Commission hastrading of shares of Wellness Matrix Group, citing statements "made through affiliated websites and a company consultant about selling at-home COVID-19 testing kits that had been approved by the FDA."
You’re reading a preview, subscribe to read more.
Start your free 30 days